Pancreatic Cancer Research

ResearcherHarold C. Simmons Comprehensive Cancer CenterNo recent work listed

Gaurab Chakrabarti

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5085285744. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 3 papers

Papers 3

  1. NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone. First author DOI 10.1038/cddis.2014.564↗
  2. Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone. Co-author DOI 10.1038/srep17066↗
  3. Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone. Co-author DOI 10.1186/s40170-015-0137-1↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zachary Moore · 3 shared papers, 2015 · strength 0.13
  2. David A. Boothman · 3 shared papers, 2015 · strength 0.13
  3. Rolf A. Brekken · 1 shared paper, 2015 · strength 0.05
  4. Molly A. Silvers · 1 shared paper, 2015 · strength 0.04
  5. Lewis C. Cantley · 1 shared paper, 2015 · strength 0.04
  6. Stanton L. Gerson · 1 shared paper, 2015 · strength 0.04
  7. Alec C. Kimmelman · 1 shared paper, 2015 · strength 0.04
  8. Costas Andreas Lyssiotis · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.